Early corticosteroid treatment enhances recovery from SARS-CoV-2 induced loss of smell in hamster
Description
Among the numerous long COVID symptoms, olfactory dysfunction persists in ∼10 % of patients suffering from SARS-CoV-2 induced anosmia. Among the few potential therapies, corticoid treatment has been used for its anti-inflammatory effect with mixed
